rs41352148

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004171.4(SLC1A2):​c.1092-1038A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 152,082 control chromosomes in the GnomAD database, including 5,230 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5230 hom., cov: 32)

Consequence

SLC1A2
NM_004171.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.681

Publications

5 publications found
Variant links:
Genes affected
SLC1A2 (HGNC:10940): (solute carrier family 1 member 2) This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]
SLC1A2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 41
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004171.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.292 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004171.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC1A2
NM_004171.4
MANE Select
c.1092-1038A>G
intron
N/ANP_004162.2
SLC1A2
NM_001439342.1
c.1080-1038A>G
intron
N/ANP_001426271.1
SLC1A2
NM_001195728.3
c.1065-1038A>G
intron
N/ANP_001182657.1P43004-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC1A2
ENST00000278379.9
TSL:1 MANE Select
c.1092-1038A>G
intron
N/AENSP00000278379.3P43004-1
SLC1A2
ENST00000395750.6
TSL:1
c.1080-1038A>G
intron
N/AENSP00000379099.2A0A2U3TZS7
SLC1A2
ENST00000644779.1
c.1203-1038A>G
intron
N/AENSP00000494258.1A0A2R8YD46

Frequencies

GnomAD3 genomes
AF:
0.258
AC:
39221
AN:
151964
Hom.:
5207
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.273
Gnomad AMI
AF:
0.200
Gnomad AMR
AF:
0.298
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.236
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.258
AC:
39287
AN:
152082
Hom.:
5230
Cov.:
32
AF XY:
0.259
AC XY:
19226
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.273
AC:
11303
AN:
41460
American (AMR)
AF:
0.299
AC:
4573
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
713
AN:
3460
East Asian (EAS)
AF:
0.211
AC:
1092
AN:
5180
South Asian (SAS)
AF:
0.0995
AC:
480
AN:
4826
European-Finnish (FIN)
AF:
0.319
AC:
3369
AN:
10574
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.250
AC:
16984
AN:
67990
Other (OTH)
AF:
0.244
AC:
513
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1490
2979
4469
5958
7448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.257
Hom.:
833
Bravo
AF:
0.259
Asia WGS
AF:
0.202
AC:
699
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
11
DANN
Benign
0.88
PhyloP100
0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41352148;
hg19: chr11-35309536;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.